Cypress Reports Third Quarter 2019 Results and Provides Update on Regulatory Approvals

1. Includes a $29.5 million impairment charge recorded for the investment in Deca Technologies, Inc.

Table C: GAAP to non-GAAP reconciling items: Three Months Ended Q3 2018

 

 

 

 

Cost of revenues

 

Research and
development

 

Selling, general
and
administrative

 

Interest and other
expense, net

GAAP [i]

 

$

413,320

 

 

$

91,691

 

 

$

92,943

 

 

$

(18,716

)

[1] Stock-based compensation

 

5,120

 

 

8,206

 

 

10,869

 

 

 

[2] Changes in value of deferred compensation plan

 

136

 

 

667

 

 

768

 

 

(1,108

)

[3] Share in gain/ loss, net of equity method investee

 

 

 

 

 

 

 

3,657

 

[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others

 

 

 

 

 

 

 

6,782

 

[5] Amortization of acquisition-related intangible assets and other

 

51,565

 

 

 

 

4,310

 

 

 

[6] Acquisition costs

 

 

 

 

 

119

 

 

 

[7] Restructuring charges

 

(340

)

 

516

 

 

9,815

 

 

 

[8] Litigation settlement and other

 

 

 

 

 

(605

)

 

(1,286

)

Non - GAAP [ii]

 

$

356,839

 

 

$

82,302

 

 

$

67,667

 

 

$

(10,671

)

Impact of reconciling items [ii - i]

 

$

(56,481

)

 

$

(9,389

)

 

$

(25,276

)

 

$

8,045

 

Table D: GAAP to non-GAAP reconciling items: Nine Months Ended Q3 2019

 

 

 

 

Cost of revenues

 

Research and
development

 

Selling, general
and
administrative

 

Interest and other
expense, net

GAAP [i]

 

$

1,028,138

 

 

$

271,498

 

 

$

255,583

 

 

$

(73,546

)

[1] Stock-based compensation

 

11,408

 

 

26,692

 

 

37,666

 

 

 

[2] Changes in value of deferred compensation plan

 

594

 

 

2,798

 

 

2,849

 

 

(5,242

)

[3] Loss (gain) from sale of NAND business to joint venture

 

2,017

 

 

 

 

1,515

 

 

(1,887

)

[4] Share in gain/loss, net and impairment of equity method investees 1

 

 

 

 

 

 

 

37,378

 

[5] Imputed interest on convertible debt, equity component amortization on convertible debt and others

 

 

 

 

 

 

 

9,745

 

[6] Amortization of debt issuance costs

 

 

 

 

 

 

 

2,484

 

[7] Loss on extinguishment of debt

 

 

 

 

 

 

 

6,402

 

[8] Amortization of acquisition-related intangible assets and other

 

142,594

 

 

 

 

12,924

 

 

 

[9] Restructuring charges and other

 

901

 

 

1,653

 

 

908

 

 

 

[10] Merger-related expenses

 

 

 

 

 

11,452

 

 

 

[11] Other income and expenses

 

 

 

338

 

 

861

 

 

(432

)

Non - GAAP [ii]

 

$

870,624

 

 

$

240,017

 

 

$

187,408

 

 

$

(25,098

)

Impact of reconciling items [ii - i]

 

$

(157,514

)

 

$

(31,481

)

 

$

(68,175

)

 

$

48,448

 


« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10  Next Page »



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise